The effects of endothelin‐1 and NG‐nitro‐l‐arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin‐induced diabetes mellitus
Open Access
- 1 June 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 103 (2) , 1321-1326
- https://doi.org/10.1111/j.1476-5381.1991.tb09787.x
Abstract
1 Resting haemodynamic status and responses to endothelin-1 (0.004, 0.04, 0.4 nmol kg−1) and NG-nitro-l-arginine methyl ester (l-NAME, 10 mg kg−1) were assessed in conscious, Wistar rats treated with streptozotocin (STZ) to induce diabetes mellitus, and in control animals treated with saline. 2 In the resting state, STZ-treated rats had a bradycardia relative to control animals (291 ± 13 and 337 ± 10 beats min−1, respectively), but mean arterial blood pressures were the same in the two groups (STZ-treated 109 ± 3; control 114 ± 4 mmHg). However, the STZ-treated rats had raised renal (105 ± 9 units) and mesenteric (114 ± 16 units) vascular conductances and reduced hindquarters vascular conductance (26 ± 4 units) relative to control rats (renal, 80 ± 6; mesenteric, 75 ± 7; hindquarters, 37 ± 3 units). 3 Increasing doses of endothelin-1 caused similar, early falls and subsequent rises in mean arterial blood pressures in both groups of rats. Although there were initial hindquarters vasodilatations with endothelin-1 that were not different in STZ-treated and control rats, there were subsequent renal and mesenteric vasoconstrictions that were greater in the former. Hence, the similar rises in mean arterial blood pressures must have been accompanied by a greater reduction in cardiac output in the STZ-treated rats. 4 l-NAME caused similar renal and mesenteric vasoconstrictions in control and STZ-treated rats, but there was a smaller pressor effect and an attenuated hindquarters vasoconstrictor response to l-NAME in STZ-treated rats. 5 Collectively, the results indicate that the resting renal and mesenteric vasodilatations in STZ-treated rats relative to control were probably not due to diminished vascular sensitivity to endogenous endothelin-1 or to enhanced sensitivity to, or production of, nitric oxide in these vascular beds. However, the relative hindquarters vasoconstriction in the resting state and the diminished hindquarters vasoconstrictor response to l-NAME in STZ-treated rats is consistent with diminished nitric oxide production in that vascular bed.Keywords
This publication has 60 references indexed in Scilit:
- Enhanced secretion of endothelin‐1 by elevated glucose levels from cultured bovine aortic endothelial cellsFEBS Letters, 1990
- Cardiac output effects of endothelin-1, -2 and -3 and sarafotoxin S6b in conscious ratsJournal of the Autonomic Nervous System, 1990
- Control of regional blood flow by endothelium-derived nitric oxide.Hypertension, 1990
- Endothelin-1 and Endothelin-3 Release EDRF from Isolated Perfused Arterial Vessels of the Rat and RabbitJournal of Cardiovascular Pharmacology, 1989
- Regional Hemodynamic Effects of Endothelin-1 in Conscious, Unrestrained, Wistar RatsJournal of Cardiovascular Pharmacology, 1989
- Does so-called streptozocin hypertension exist in rats?Hypertension, 1987
- Depressor effect of diabetes in the spontaneously hypertensive rat: associated changes in heart performanceCanadian Journal of Physiology and Pharmacology, 1986
- Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness.Hypertension, 1982
- Vagal control of heart period in alloxan diabetic ratsLife Sciences, 1982
- β-Adrenergic receptor decrease in diabetic rat heartsLife Sciences, 1979